PDF Version (1 Page, 93 KB)
PROTOCOL
Treating physicians will inform public health of suspect/probable SARS cases involving receiving fresh blood products.
Public health should ask if the patients of suspect or probable cases has received a blood transfusion during the 10 days prior to the onset of their fever.
If no, this risk factor is eliminated.
If yes, collect the following information:
Public health immediately to inform the local hospital bloodbank that has issued the blood. Provincial traceback/lookback procedures will be activated, which includes informing CBS/Héma-Québec.
CBS/Héma-Québec will activate their trace back procedures.
Health Canada Biologic and Genetic Therapies Directorate will be informed through the CBS/Héma-Québec.
Regulatory action will be given by Biologics and Genetic Therapies Directorate to CBS/Héma-Québec for further actions and follow-up.
Public health officials determine if further actions are needed based on diagnostic testing results on the blood donor.
Prepared by:
Dr. Antonio Giulivi
Director, BSSHCAID/CIDPC/PHAC
April 16, 2003